217 related articles for article (PubMed ID: 22768167)
1. A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein.
Rogers MS; Cryan LM; Habeshian KA; Bazinet L; Caldwell TP; Ackroyd PC; Christensen KA
PLoS One; 2012; 7(6):e39911. PubMed ID: 22768167
[TBL] [Abstract][Full Text] [Related]
2. Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells.
Chen KH; Liu S; Bankston LA; Liddington RC; Leppla SH
J Biol Chem; 2007 Mar; 282(13):9834-9845. PubMed ID: 17251181
[TBL] [Abstract][Full Text] [Related]
3. Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting.
Chen KH; Liu S; Leysath CE; Miller-Randolph S; Zhang Y; Fattah R; Bugge TH; Leppla SH
J Biol Chem; 2016 Oct; 291(42):22021-22029. PubMed ID: 27555325
[TBL] [Abstract][Full Text] [Related]
4. Identification of small molecules that inhibit the interaction of TEM8 with anthrax protective antigen using a FRET assay.
Cryan LM; Habeshian KA; Caldwell TP; Morris MT; Ackroyd PC; Christensen KA; Rogers MS
J Biomol Screen; 2013 Jul; 18(6):714-25. PubMed ID: 23479355
[TBL] [Abstract][Full Text] [Related]
5. The receptors that mediate the direct lethality of anthrax toxin.
Liu S; Zhang Y; Hoover B; Leppla SH
Toxins (Basel); 2012 Dec; 5(1):1-8. PubMed ID: 23271637
[TBL] [Abstract][Full Text] [Related]
6. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.
Scobie HM; Rainey GJ; Bradley KA; Young JA
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5170-4. PubMed ID: 12700348
[TBL] [Abstract][Full Text] [Related]
7. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo.
Liu S; Crown D; Miller-Randolph S; Moayeri M; Wang H; Hu H; Morley T; Leppla SH
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12424-9. PubMed ID: 19617532
[TBL] [Abstract][Full Text] [Related]
8. Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2.
Verma A; Moayeri M; Mocca CP; O'Mard D; Ma Q; Leppla SH; Burns DL
Vaccine; 2022 Jul; 40(32):4318-4321. PubMed ID: 35710508
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the interaction between anthrax toxin and its cellular receptors.
Liu S; Leung HJ; Leppla SH
Cell Microbiol; 2007 Apr; 9(4):977-87. PubMed ID: 17381430
[TBL] [Abstract][Full Text] [Related]
10. The CMG2 ELISA for evaluating inhibitors of the binding of anthrax toxin protective antigen to its receptor.
Dawson RM
J Pharmacol Toxicol Methods; 2009; 59(1):50-5. PubMed ID: 19049885
[TBL] [Abstract][Full Text] [Related]
11. Capillary morphogenesis gene 2 (CMG2) mediates growth factor-induced angiogenesis by regulating endothelial cell chemotaxis.
Cryan LM; Tsang TM; Stiles J; Bazinet L; Lee SL; Garrard S; Madrian E; Roberts C; Payne J; Jensen A; Frankel AE; Ackroyd PC; Christensen KA; Rogers MS
Angiogenesis; 2022 Aug; 25(3):397-410. PubMed ID: 35212873
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of the interaction between the anthrax toxin and its cellular receptor by an anti-receptor monoclonal antibody.
Li G; Qu Y; Cai C; Kong Y; Liu S; Zhang J; Zhao J; Fu L; Xu J; Chen W
Biochem Biophys Res Commun; 2009 Aug; 385(4):591-5. PubMed ID: 19486894
[TBL] [Abstract][Full Text] [Related]
13. Receptor-specific requirements for anthrax toxin delivery into cells.
Rainey GJ; Wigelsworth DJ; Ryan PL; Scobie HM; Collier RJ; Young JA
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13278-83. PubMed ID: 16141341
[TBL] [Abstract][Full Text] [Related]
14. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen.
Wigelsworth DJ; Krantz BA; Christensen KA; Lacy DB; Juris SJ; Collier RJ
J Biol Chem; 2004 May; 279(22):23349-56. PubMed ID: 15044490
[TBL] [Abstract][Full Text] [Related]
15. Heterodimeric integrin complexes containing beta1-integrin promote internalization and lethality of anthrax toxin.
Martchenko M; Jeong SY; Cohen SN
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15583-8. PubMed ID: 20713715
[TBL] [Abstract][Full Text] [Related]
16. Interactions between anthrax toxin receptors and protective antigen.
Scobie HM; Young JA
Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
[TBL] [Abstract][Full Text] [Related]
17. Tumor endothelium marker-8 based decoys exhibit superiority over capillary morphogenesis protein-2 based decoys as anthrax toxin inhibitors.
Cai C; Che J; Xu L; Guo Q; Kong Y; Fu L; Xu J; Cheng Y; Chen W
PLoS One; 2011; 6(6):e20646. PubMed ID: 21674060
[TBL] [Abstract][Full Text] [Related]
18. Stability of domain 4 of the anthrax toxin protective antigen and the effect of the VWA domain of CMG2 on stability.
Mamillapalli S; Miyagi M; Bann JG
Protein Sci; 2017 Feb; 26(2):355-364. PubMed ID: 27874231
[TBL] [Abstract][Full Text] [Related]
19. Targeting Bacillus anthracis toxicity with a genetically selected inhibitor of the PA/CMG2 protein-protein interaction.
Male AL; Forafonov F; Cuda F; Zhang G; Zheng S; Oyston PCF; Chen PR; Williamson ED; Tavassoli A
Sci Rep; 2017 Jun; 7(1):3104. PubMed ID: 28596569
[TBL] [Abstract][Full Text] [Related]
20. The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin.
Fu S; Tong X; Cai C; Zhao Y; Wu Y; Li Y; Xu J; Zhang XC; Xu L; Chen W; Rao Z
PLoS One; 2010 Jun; 5(6):e11203. PubMed ID: 20585457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
